SRNE News and Press, Sorrento Therapeutics Inc. From 02/11/21

Short sellers have their eyes peeled on Vir Biotechnology (NASDAQ: VIR) and Sorrento Therapeutics (NASDAQ: SRNE) . Short positions make up 22% and 26% of their float, respectively. Float refers to shares available for the general public to trade. The immediate risk lies ...

China Oncology Focus Limited (COF) announces that anti-PD-L1 antibody, socazolimab, licensed from Sorrento Therapeutics (SRNE) for the greater China territory, has been granted breakthrough therapy designation ((BTD)) by the China National Medical Products Administration ((NMPA...

Socazolimab is an anti-PD-L1 antibody licensed from Sorrento for the Greater China Territory by Lee’s Pharma. China National Medical Products Administration (NMPA) grants breakthrough Therapy Designation (BTD) to socazolimab for the cervical cancer indication. Lee’s ...

Sorrento Therapeutics shares jump ([[SRNE]] +16.5%) after it announces the formation of ADNAB, a subsidiary company, that will develop and commercialize a Mayo Clinic-developed technology platform for the manufacture of antibody-drug conjugates ((ADC)) called ADNAB.ADNAB is an immune com...

The ADNAB™ platform was developed and exclusively licensed to Sorrento by the Mayo Clinic Clinical studies utilizing the ADNAB™ platform are ongoing at the Mayo Clinic; and are evaluating multiple platform-generated products in advanced-stage: endometrial cancer, ova...

Sorrento Therapeutics has recently disclosed positive results in anti-COVID allogeneic adipose stem cells research. Sorrento Therapeutics is among the Nasdaq stocks with the highest short interest at 26.8%. I believe that the combination of a strong research pipeline with high sho...

Palm Beach, FL – February 2, 2021 – Recent reports of ongoing testing regarding the length of time that the initially approved vaccines for COVID-19 will give the patients for immunity after having been inoculated with the vaccine.  Early in the covid-19 pandemic it was u...

Sorrento Therapeutics (SRNE) jumps 14% premarket following an update to the previous Phase 1b results of COVI-MSC study in COVID-19.On January 27, SRNE announced that the first three enrolled ICU COVID-19 patients were discharged from the hospital within a week&#...

Fourth patient, who spent more than two weeks in hospital and needed invasive mechanical ventilation, was treated with COVI-MSC starting Monday (January 25, 2021) and discharged last Friday (January 29, 2021) after 3rd COVI-MSC infusion To date, 4/4 ICU COVID-19 patients were discha...

It’s like a bizarro Nifty Fifty.Robinhood (RBNHD) currently has an expanded list of 50 equities where buying shares and options contracts is limited (see full list below with recent performance). On the list, 35 are limited to one whole share (no fractional trading in these stocks) and...